Ectomesenchymal chondromyxoid tumor: histopathologic and immunohistochemical study of two cases without a chondroid component

J Cutan Pathol. 2012 Aug;39(8):781-6. doi: 10.1111/j.1600-0560.2012.01910.x. Epub 2012 Jun 19.

Abstract

Ectomesenchymal chondromyxoid tumor (ECT) is a rare benign neoplasm usually affecting the anterior dorsum of the tongue. Histopathologically, it is formed by spindle, round and/or polygonal cells embedded in a chondromyxoid matrix. Immunohistochemical positivity for vimentin, S-100 protein, glial fibrillary acid protein and neuron-specific enolase are helpful to confirm the diagnosis. There are 42 cases of ECT of the tongue reported in the English language literature, three of them showing no chondroid matrix. We describe two additional cases of ECT lacking the chondroid component, exhibiting areas of reticulated myxoid and cellular pattern. Considering the microscopical features, ECT can be classified in classic and 'chondroid-free' variants, the latter including the reticulated myxoid and cellular patterns. It is important to consider that the cellular ECT usually exhibits predominance of an infiltrative atypical cellular component that may mimic a malignant tumor.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / metabolism
  • Cartilage / pathology*
  • Chondroma / metabolism
  • Chondroma / pathology*
  • Chondroma / surgery
  • Female
  • Glial Fibrillary Acidic Protein / metabolism
  • Humans
  • Immunohistochemistry / methods
  • Mesenchymoma / metabolism
  • Mesenchymoma / pathology*
  • Mesenchymoma / surgery
  • Myxoma / metabolism
  • Myxoma / pathology*
  • Myxoma / surgery
  • Phosphopyruvate Hydratase / metabolism
  • S100 Proteins / metabolism
  • Tongue Neoplasms / metabolism
  • Tongue Neoplasms / pathology*
  • Tongue Neoplasms / surgery
  • Treatment Outcome
  • Vimentin / metabolism

Substances

  • Biomarkers, Tumor
  • Glial Fibrillary Acidic Protein
  • S100 Proteins
  • Vimentin
  • Phosphopyruvate Hydratase